Annotation Detail

Information
Associated Genes
DNMT3A
Associated Variants
DNMT3A R882
DNMT3A R882
Associated Disease
acute myeloid leukemia
Source Database
CIViC Evidence
Description
In young AML patients (<60 years old), DNMT3A mutation status (60% of which were R882) was not predictive of overall and relapse free survival in patients with NPM1 mutations and wildtype FLT3 or wildtype NPM1 and FLT3-ITD.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/51
Gene URL
https://civic.genome.wustl.edu/links/genes/18
Variant URL
https://civic.genome.wustl.edu/links/variants/32
Rating
4
Evidence Type
Prognostic
Disease
Acute Myeloid Leukemia
Evidence Direction
Does Not Support
Evidence Level
B
Clinical Significance
N/A
Pubmed
22490330
Drugs